Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00739700 · ClinicalTrials.gov registry record
Non-invasive Blood Pressure (BP) Monitoring Compared to A-Line BP Monitoring
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 116
- Enrollment target
NCT00739700: Completed study, sponsored by Wake Forest University Health Sciences.
NCT00739700 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 116 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00739700 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 116 participants
- Enrollment target
Study Summary
Blood pressure cuffs (NIBP) are slowly replacing intra-arterial (IABP) measurement as the standard of care in the medical intensive care unit. There is little data to support this clinical normalization of deviance. This study aims to correlate NIBP with IABP.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2007-06 |
| Est. Completion | 2016-12 |
What the finished NCT00739700 record still lists
NCT00739700 is an observational study that tracks outcomes without assigning an intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00739700 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00739700 about?
NCT00739700 is a clinical study titled "Non-invasive Blood Pressure (BP) Monitoring Compared to A-Line BP Monitoring". Blood pressure cuffs (NIBP) are slowly replacing intra-arterial (IABP) measurement as the standard of care in the medical intensive care unit. There is little data to support this clinical normalization of deviance. This study aims to correlate NIBP with IABP.
What is the current status of trial NCT00739700?
This trial is currently completed. The enrollment target is 116 participants. The study started on 2007-06. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT00739700?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia